News
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...
Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
Daniel Drucker, Ozempic’s father: ‘I’m very conservative. I don’t sell the drugs. I study the drugs’
The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
Ozempic, which is prescribed for diabetes, and Wegovy, prescribed for weight loss, both contain the active ingredient ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results